Mayo Clinic
Rochester, Minnesota, 55905, United States
NCT Number: NCT06268951
To determine the characteristics of recovery and symptom relief following ablation of abdominal wall endometriosis.
Interested in participating?
Request InfoFemale
Observational
Rochester, Minnesota, 55905, United States
The purpose of this study is to characterize the recovery and symptom relief following cryoablation of abdominal wall endometriosis. Patients undergoing clinically indicated ablation of abdominal wall endometriosis will receive an endometriosis-specific symptom survey (Endometriosis Health Profile - 30) prior to ablation and then at 3-, 6-, 12-, and 24-months following treatment. A 2 question survey related to pain at the treatment site will also be administered prior to ablation and then at 1-, 7-, and 30-days after ablation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline and intermittently over 24 months
Using the Endometriosis Health Profile - 30 survey, the impact of ablation on endometriosis-related symptoms will be quantified over time. A numerical rating scale will be used to quantify pain at the site of treated abdominal wall endometriosis.
Mayo Clinic
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05059626
Endometriosis, Female Urogenital Diseases
New Haven, Connecticut, United States
View Trial DetailsNCT05411549
Endometriosis, Female Urogenital Diseases
Hamilton, Ontario, Canada
View Trial DetailsNCT05523284
Disease, Endometriosis
Hamilton, Ontario, Canada
View Trial DetailsNCT05601596
Disease, Endometriosis
Manhasset, New York, United States
View Trial Details